Reports for ABBVIE CORPORATION

Company Name

ABBVIE CORPORATION

Totals

Shortage reports

112

Actual shortage: 3 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 104 (93%)

Discontinuation Reports

9

To be discontinued: 0 (0%)
Discontinued: 8 (89%)
Reversed: 1 (11%)

Late reports

3 (2%)

Overdue reports

1 (33%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALPHAGAN P 0.15% SOLUTION Resolved 2023-08-14 2023-11-28 201805
CONSTELLA 290MCG CAPSULE Resolved 2023-09-08 2023-09-22 203963
VIIBRYD 20MG TABLET Resolved 2023-09-11 2023-09-29 204062
BYSTOLIC 2.5MG TABLET Resolved 2023-10-11 2023-11-23 206797
SURVANTA 25MG SUSPENSION Avoided shortage 2023-10-12 2023-12-01 206915
SURVANTA 25MG SUSPENSION Avoided shortage 2023-10-12 2023-12-01 206918
ZYMAR 0.3% SOLUTION Resolved 2023-11-14 2023-12-07 210159
VIIBRYD 10MG TABLET Resolved 2023-12-07 2024-01-16 212766
VIIBRYD 20MG TABLET Resolved 2023-12-07 2023-12-08 212769
OCUFLOX 0.3% SOLUTION Actual shortage 2024-01-29 2024-05-16 217532
SURVANTA 25MG SUSPENSION Resolved 2024-04-24 2024-05-11 226027
VIIBRYD 20MG TABLET Actual shortage 2024-05-16 2024-05-17 228152

Showing 101 to 112 of 112

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MODERIBA 600MG TABLET Discontinued 2017-11-20 2018-05-07 29835
TECHNIVIE 12.5MG 75MG 50MG TABLET Discontinued 2017-11-20 2018-05-07 29839
MODERIBA 200MG TABLET Discontinued 2017-11-21 2018-08-30 29907
HOLKIRA PAK 50MG 12.5MG 250MG 75MG KIT TABLET Discontinued 2017-11-30 2018-08-30 31302
MODERIBA 400MG TABLET Discontinued 2017-11-30 2018-08-30 31316
NORVIR 80MG SOLUTION Discontinued 2019-02-20 2019-04-01 76354
HUMIRA 40MG SOLUTION Discontinued 2020-06-29 2020-11-19 119141
ALPHAGAN 0.2% LIQUID Reversed 2021-12-09 2023-12-14 150885
LUPRON 5MG SOLUTION Discontinued 2022-01-31 2022-08-17 153896

Showing 1 to 9 of 9